We have collected the most relevant information on Audion Therapeutics Hearing Loss. Open the URLs, which are collected below, and you will find all the info you are interested in.
Hearing Loss - Audion Therapeutics
https://audiontherapeutics.com/hearing-loss/
Audion’s lead program AUD1001 aims to change that, and provides a pharmacological treatment that can potentially address the needs of a large number of people suffering from acquired sensorineural hearing loss.
Home - Audion Therapeutics
https://audiontherapeutics.com/
Audion Therapeutics is a clinical-stage company dedicated to the development of therapies to treat Hearing Loss About Audion Hearing Loss Acquired Sensorineural Hearing Loss (SNHL), due to aging, exposure to noise or other environmental …
About Audion - Audion Therapeutics
https://audiontherapeutics.com/about-audion/
Audion Therapeutics is a clinical-stage company dedicated to the development of therapies to treat Hearing Loss. Our lead program is aimed at regenerating cells and neuronal connections that are lost in patients with acquired Sensorineural Hearing Loss (SNHL), which is the most prevalent form of Hearing Loss. The program is based on scientific discoveries from the Edge …
Eli Lilly-Backed Audion Therapeutics Initiates Phase 2 ...
https://www.hearinglosstreatmentreport.com/eli-lilly-backed-audion-therapeutics-initiates-phase-2-clinical-trial-of-aud1001-ly3056480-in-patients-with-sensorineural-hearing-loss/
Eli Lilly-Backed Audion Therapeutics Initiates Phase 2 Clinical Trial of AUD1001 (LY3056480) in Patients with Sensorineural Hearing Loss. October 1, 2021. The official record for the study, “A Phase 2 Double Blind, Randomized, Placebo Controlled Trial inVEstigating the Effect and Safety of Several Dosing Regimens of LY3056480 in Patients With STAble Sensorineural Hearing Loss”, …
Development - Audion Therapeutics
https://audiontherapeutics.com/development/
Audion is preparing for initiation of new clinical trials of AUD1001 for sensorineural hearing loss at multiple sites in Europe and in the US in H2 2021. The planned Phase 2b double blind, placebo controlled trials will be conducted in adults with demonstrated loss of clarity, using a standardized local drug delivery.
Audion Therapeutics | VentureRadar
https://www.ventureradar.com/organisation/Audion%20Therapeutics/9dbdb17e-ce9d-457c-9d29-7832292a7d94
Audion Therapeutics and REGAIN Consortium Announce ...
https://www.b3cnewswire.com/201902051883/audion-therapeutics-and-regain-consortium-announce-positive-phase-i-results-in-patients-with-sensorineural-hearing-loss.html
AMSTERDAM, The Netherlands, February 05, 2019 / B3C newswire / --The REGAIN consortium, led by Audion Therapeutics BV, a company dedicated to the development of therapeutics for hearing loss, today reports positive results from its Phase I multiple ascending dose, open-label safety study of the Notch Inhibitor LY3056480 in 15 patients with mild to …
Now you know Audion Therapeutics Hearing Loss
Now that you know Audion Therapeutics Hearing Loss, we suggest that you familiarize yourself with information on similar questions.
